Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 320

Results For "ASH"

3331 News Found

Granules India recalls one batch of Naproxen Sodium 220mg tablets
News | September 13, 2021

Granules India recalls one batch of Naproxen Sodium 220mg tablets

One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled


Advanced Enzyme supplements pass clinical trials for efficacy
Biotech | September 13, 2021

Advanced Enzyme supplements pass clinical trials for efficacy

This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life


Everest Medicines ties up with Providence Therapeutics to supply Covid-19 vaccines in Asia
Biotech | September 13, 2021

Everest Medicines ties up with Providence Therapeutics to supply Covid-19 vaccines in Asia

Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer


US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma
Drug Approval | September 12, 2021

US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma

Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma


Evexia Lifecare on expansion mode
News | September 09, 2021

Evexia Lifecare on expansion mode

The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


Merck’s KEYTRUDA receives China approval for Esophageal cancer
Drug Approval | September 09, 2021

Merck’s KEYTRUDA receives China approval for Esophageal cancer

The medicine is now approved for eight indications across five different types of cancer in China.


Sun Pharma Consumer Healthcare launch Revital NXT nutrition bar
Healthcare | September 08, 2021

Sun Pharma Consumer Healthcare launch Revital NXT nutrition bar

The company said Revital NXT is India’s first nutrition bar with the goodness of natural ginseng, 16 vitamins & minerals and triple blend protein


Sanofi buys Kadmon to grow its transplant business
Biotech | September 08, 2021

Sanofi buys Kadmon to grow its transplant business

It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)


HUL funds study on Covid-19 vulnerability and vaccine efficiency
News | September 07, 2021

HUL funds study on Covid-19 vulnerability and vaccine efficiency

The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.